Global Glycomics Market is expected to foresee significant growth during the forecast period. North America to witness the highest growth
Global Glycomics Market is expected to reach the market valuation of USD XX million by 2027 expanding at a reasonable CAGR of XX% during the forecast period (2021-2027) from USD XX million in 2020. Glycomics is the study of the ‘glycome’ which is the entire complement of sugars in a cell. Every cell in the human body is decorated with these sugars and plays an important role in the development of a disease. It is a relatively new field of research in comparison to genomics and proteomics.
The various factors driving the growth of the glycomics market include technological advancements, rising investment in Glycomics research, and an increase in the number of partnerships & collaborations. For instance, recently in June 2021, Waters Corporation has collaborated with Singapore’s Bioprocessing Technology Institute to work on a new collaborative project that would apply analytics to rapidly identify & visualize complex molecules within glycomics and metabolomics data to help ensure overall safety, accuracy, and speed of biologics manufacturing. Furthermore, the upsurge in demand for medicines globally is because of the growing burden of diseases including cancer and other chronics diseases. For instance, as per the American Cancer Society, in 2021, there will be an estimated 1.9 million new cancer cases diagnosed and 608,570 cancer deaths in the United States. Owing to these alarming facts, the need for developing new and effective drugs has increased which in turn, is driving more investment in research & development activities related to glycomics. Thereby, augmenting the Glycomics market globally.
For a detailed analysis of the glycomics market browse through - https://univdatos.com/report/glycomics-market
Additionally, with the growing interest of researchers for glycomics research and the rise in funding for its research, the market is flourishing with numerous startups providing glycomics solutions. For example, Gnubiotics is a Swiss startup that develops glycans as microbiome modulators. The Glycan Microbiome Modulators (GMM) platform provide by this startup identifies glycans that develop and restore microbiome diversity. It develops AMObiome that is a natural ingredient that helps in improving an animal’s gut health. However, some of the restraints in the market include ethical & legal limitations and the lack of a skilled workforce. Besides, the high cost of tools is another factor impeding the growth of this market all over the world.
For a detailed analysis of the market drivers of glycomics market browse through - https://univdatos.com/report/glycomics-market
Based on products, the market is fragmented into enzymes, instruments, reagents, kits, and others. The enzyme segment dominated the market in 2020 and generated total revenue of USD XX million. However, the instruments segment also grabbed a considerable share of the global glycomics market owing to the technological advancement and the number of initiatives by key industry players to launch new and advanced products in the market. For instance, in 2018, Shimadzu Corporation and PREMIER Biosoft collaborated to launch a comprehensive lipid and glycan analysis platform by using Shimadzu's new Q-TOF mass spectrometer. Based on Application, the market is fragmented into diagnostics, drug discovery & development, and others. The drug discovery & development segment dominated the market in 2020 and generated total revenue of USD XX million. It is anticipated to maintain its dominance during the forecast period owing to the increasing demand for products of glycomics in drug discovery & development coupled with the rising applications of glycomics in biomarker identification. For instance, in 2021, researchers at The Wistar Institute which is an international leader in biomedical research identified metabolic and glycomic biomarkers in the blood of a rare population of HIV-infected individuals who can naturally sustain viral suppression after ART cessation, known as post-treatment controllers.
Request for Sample of the report browse through - https://univdatos.com/request_form/form/469
Additionally, the report provides detailed initiatives that are being taken in the field of glycomics. The market is classified into distinct regions North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of APAC), Rest of World has been conducted. North America dominated the market and generated revenue of USD XX million in 2020 owing to the increasing cancer incidence, higher government-funded initiatives, and increasing R&D investment by key industry players. At the same time, Asia-Pacific is anticipated to grow at the highest CAGR of XX% during the forecast period. Thermo Fisher Scientific, Agilent Technologies, Danaher, Merck KGaA, RayBiotech, Shimadzu Corporation, Takara Bio, New England Biolabs, S-BIO, Waters Corporation, etc are some of the prominent players operating in the global glycomics market. Several M&A’s along with partnerships have been undertaken by these players to develop new and advanced Glycomics tools.
Global Glycomics Market Segmentation
Market Insight, by Product
- Mass Spectrometers
- Array Systems
- Glycan Labeling Kits
- Glycan Purification Kits
- Glycan Release Kits
Market Insight, by Application
- Drug Discovery and Development
Market Insight, by End-User
- Pharmaceutical & Biotechnology Companies
- Academic Research Institutes
- Clinical Laboratories
Market Insight, by Region
- North America Glycomics Market
- United States
- Rest of North America
- Europe Glycomics Market
- United Kingdom
- Rest of Europe
- Asia-Pacific Glycomics Market
- Rest of Asia-Pacific
- Rest of World Glycomics Market
Top Company Profiles
- Agilent Technologies
- Thermo Fisher Scientific
- Merck KGaA
- Shimadzu Corporation
- Takara Bio
- New England Biolabs
- Waters Corporation